Marc Wiles - Aptose Biosciences Senior Affairs
| APS Stock | CAD 0.25 0.01 3.85% |
Executive
Marc Wiles is Senior Affairs of Aptose Biosciences
| Address | 251 Consumers Road, Toronto, ON, Canada, M2J 4R3 |
| Phone | 647 479 9828 |
| Web | https://www.aptose.com |
Aptose Biosciences Management Efficiency
The company has return on total asset (ROA) of (1.3629) % which means that it has lost $1.3629 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.9413) %, meaning that it generated substantial loss on money invested by shareholders. Aptose Biosciences' management efficiency ratios could be used to measure how well Aptose Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aptose Biosciences' Return On Capital Employed is very stable compared to the past year. As of the 27th of November 2024, Return On Equity is likely to grow to 18.53, though Return On Tangible Assets are likely to grow to (3.75). At this time, Aptose Biosciences' Non Current Assets Total are very stable compared to the past year. As of the 27th of November 2024, Other Current Assets is likely to grow to about 2.8 M, while Total Assets are likely to drop about 12.3 M.Similar Executives
| Found 9 records | EXECUTIVE Age | ||
| BBA CM | Oncolytics Biotech | N/A | |
| Amy Levin | Oncolytics Biotech | N/A | |
| PMP PEng | Oncolytics Biotech | N/A | |
| BBA FCA | Oncolytics Biotech | N/A | |
| Andres Gutierrez | Oncolytics Biotech | 58 | |
| MD FCAP | Medicenna Therapeutics Corp | N/A | |
| CBV CA | Medicenna Therapeutics Corp | 51 | |
| RN BSN | Oncolytics Biotech | N/A | |
| Wayne MBA | Oncolytics Biotech | 69 | |
Management Performance
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.36 |
Aptose Biosciences Leadership Team
Elected by the shareholders, the Aptose Biosciences' board of directors comprises two types of representatives: Aptose Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptose. The board's role is to monitor Aptose Biosciences' management team and ensure that shareholders' interests are well served. Aptose Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptose Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philippe Ledru, Senior Officer | ||
| Fletcher Payne, CFO, VP | ||
| Janet CA, VP Fin | ||
| Rafael MD, Senior Officer | ||
| Roger BSc, Vice Operations | ||
| Marc Wiles, Senior Affairs | ||
| Brooks MBA, VP Controller | ||
| William Rice, Chairman, CEO and Pres |
Aptose Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptose Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.36 | ||||
| Current Valuation | (5.39 M) | ||||
| Shares Outstanding | 19.52 M | ||||
| Shares Owned By Insiders | 15.87 % | ||||
| Shares Owned By Institutions | 16.68 % | ||||
| Number Of Shares Shorted | 2.36 K | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 68.22 X | ||||
| EBITDA | (52.27 M) |
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptose Stock
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.